Literature DB >> 27792212

Postoperative analgesia for elective total knee arthroplasty under subarachnoid anesthesia with opioids: comparison between epidural, femoral block and adductor canal block techniques (with and without perineural adjuvants). A prospective, randomized, clinical trial.

José R Ortiz-Gómez1, Marta Perepérez-Candel2, José M Vázquez-Torres2, José M Rodriguez-Del Río2, Berta Torrón-Abad2, Inocencia Fornet-Ruiz3, Francisco J Palacio-Abizanda4.   

Abstract

BACKGROUND: Optimal control of acute postoperative pain and prevention of chronic persistent pain in total knee arthroplasty (TKA) remain a challenge. The main hypothesis was that nerve blocks improve postoperative analgesia especially if perineural adjuvants are added.
METHODS: Immediate postoperative pain (24 hours) was evaluated every hour in 639 patients using a verbal rating 11-point scale for patient self-reporting of pain (VRS-11). All patients received subarachnoid anesthesia and were randomly allocated in 8 groups: control group, epidural (EA) and single shots femoral (FNB) or adductor canal blocks (ACB), both with and without adjuvants: dexamethasone (+Dexa) or dexmedetomidine (+Dexm). Patients received intravenous analgesia (metamizole magnesium, dexketoprofen) and rescue analgesia when needed, intravenous (paracetamol and morphine) and/or regional (epidural boluses, femoral and sciatic nerve blocks). Demographics, orthopedic knee scores and adverse effects were also recorded.
RESULTS: A 45.2% of patients had no immediate postoperative pain (P=0.0001). Rescue analgesia was needed in 48.8% of patients (P=0.0001): control group 72.8% of patients, EA 51.9%, FNB 40.0%, FNB+Dexa 33.3%, BNF+Dexm 41.3%, ACB 51.9%, ACB+Dexa 38.3% and ACB+Dexm 61.5% respectively. There were also differences in the total postoperative time without pain (P=0.0001), with mild (P=0.0001) or moderate pain (P=0.001) but not with severe pain (P=0.119).
CONCLUSIONS: Peripheral nerve blocks with perineural dexamethasone improve postoperative analgesia for TKA. The addition of dexamethasone to adductor canal block open new possibilities to improve analgesia for TKA, and should be investigated as an alternative to femoral nerve block.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27792212     DOI: 10.23736/S0375-9393.16.11646-3

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  5 in total

1.  Adductor canal blocks for postoperative pain treatment in adults undergoing knee surgery.

Authors:  Alexander Schnabel; Sylvia U Reichl; Stephanie Weibel; Peter K Zahn; Peter Kranke; Esther Pogatzki-Zahn; Christine H Meyer-Frießem
Journal:  Cochrane Database Syst Rev       Date:  2019-10-26

2.  Implementation and Postoperative Management of Continuous Adductor Canal Catheters for Total Knee Arthroplasty to Reduce Surgical Backlog Related to the COVID-19 Pandemic: An Acute Pain Service Nursing Perspective and Educational Resource.

Authors:  Tara J Faraoni; Richelle Kruisselbrink
Journal:  J Perianesth Nurs       Date:  2022-04-29       Impact factor: 1.295

3.  Evaluation of analgesic efficacy of dexmedetomidine as adjuvant with ropivacaine in ultrasound-guided adductor canal block in patients following anterior cruciate ligament reconstruction surgeries.

Authors:  Deepak Thapa; Vanita Ahuja; Khushboo Pandey; Satinder Gombar; Ravi Gupta
Journal:  Br J Pain       Date:  2018-08-30

4.  Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis.

Authors:  Yan Li; Zhi Dou; Liqiang Yang; Qi Wang; Jiaxiang Ni; Jun Ma
Journal:  Eur J Med Res       Date:  2021-01-09       Impact factor: 2.175

5.  Efficacy of interspace between the popliteal artery and the capsule of the posterior knee (iPACK) block versus periarticular local infiltration analgesia after unilateral total knee arthroplasty: Prospective randomized control trial.

Authors:  Abdul Sattar Narejo; Fatima Abdulwahab; Mansoor Aqil; Abdullah T Alsubaie; Hassan Y Hazazy; Tariq Alzahrani; Abdulaziz Aljurayyan; Ahmed Thallaj
Journal:  Saudi Med J       Date:  2021-10       Impact factor: 1.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.